GLP-1

Name: GLP-1
Brand: Canada Peptides
Price: 111.0 CAD
Availability: InStock

$111.00

$111.00 ~~$147.00~~

Sold out

This batch of GLP-1 Peptide has been third party lab tested and verified for quality.

Contents: GLP-1 (Glucagon-Like Peptide-1, Incretin Hormone Analog)
Form: Powder
Purity: 99.3%

TESTED FOR:

PURITY

WEIGHT

STERILITY

ENDOTOXINS(LPS)

Product variants

Quantity

Free Reconstitution Solution automatically added to your cart with each order.

This product is Made, Tested & Shipped From Canada.

🚚

Shipping & Delivery

We are committed to delivering fast, reliable, and transparent shipping for all orders. Please review our policy below for details on delivery times, tracking, and what to expect with every purchase.

View Full Shipping Policy

99%+ Purity Guaranteed

COA
Verified+

Trackable Shipping

View full details

GLP-1 Peptide

GLP-1 is a synthetic polypeptide modeled after the endogenous glucagon-like peptide-1 secreted from intestinal L-cells. It is investigated for its potential interaction with GLP-1 receptors located on pancreatic, gastrointestinal, and central nervous system tissues. These studies explore possible roles in insulin support, glucagon regulation, and appetite-related signal pathways.

GLP-1 has been examined in glucose-responsive endocrine functions. It may support insulin output in hyperglycemic conditions with limited influence during low-glucose states. Researchers have also evaluated its involvement in gastric emptying and satiety responses mediated by specific neural regions.

Overview

Research continues to assess GLP-1 activity across metabolic endpoints, including glucose tolerance, adipose distribution, lipid profiles, and energy intake behaviors. Investigators also explore broader cardiometabolic considerations and emerging neuroactive actions possibly linked to cognitive function and neuronal resilience.

Chemical Makeup

A single definitive molecular formula is not listed here due to preparation variability across GLP-1 research analogs. Analytical confirmation is based on direct batch testing.

Observed Mass (MS): 711.9 Da
Purity (HPLC): 99.42%
Batch Number: 2025007
Primary Retention Time: 3.48 min
Instrument: LCMS-7800 Series (Calibrated)
Comment: Primary peak confirmed by mass and retention time; trace secondary peak 0.58% area

Research and Clinical Studies

GLP-1 and Glucose Regulation
GLP-1 may influence glucose handling by supporting beta-cell signaling when glucose is elevated, while concurrently moderating glucagon release. This activity is studied for potential contributions to glycemic stability in multiple controlled settings.

GLP-1 and Appetite Control
Investigations into GLP-1 receptor activation in the brainstem and hypothalamus have reported reduced energy intake associated with enhanced satiety signaling and modulation of reward-driven consumption behaviors.

GLP-1 and Weight Management
Controlled trials of GLP-1 analogs have documented reductions in body weight and visceral adipose tissue in select models. These responses are evaluated in relation to energy balance regulatory mechanisms.

GLP-1 and Cardiometabolic Parameters
GLP-1 is being explored for its potential influence on lipid metabolism, vascular function, oxidative stress, and blood pressure regulation. Findings suggest relevance to broader cardiometabolic support.

GLP-1 and Neurological Pathways
Ongoing research is examining GLP-1 for its possible roles in neuronal survival, synaptic function, and cognitive performance. Experimental models continue to assess whether receptor activation may support neural integrity.

GLP-1 peptide is provided strictly for research and laboratory applications. Not for human or veterinary use.

References

Holst JJ. The physiology of glucagon-like peptide 1. Physiol Rev. 2007 Oct;87(4):1409-39. doi: 10.1152/physrev.00034.2006. PMID: 17928588.
https://pubmed.ncbi.nlm.nih.gov/17928588/
Nauck MA, Meier JJ. Incretin hormones: their role in health and disease. Diabetes Obes Metab. 2018 Feb;20 Suppl 1:5-21. doi: 10.1111/dom.13129. PMID: 29364587.
https://pubmed.ncbi.nlm.nih.gov/29364587/
Lovshin JA, Drucker DJ. Incretin-based therapies for type 2 diabetes mellitus. Nat Rev Endocrinol. 2009 May;5(5):262-9. doi: 10.1038/nrendo.2009.48. PMID: 19444259.
https://pubmed.ncbi.nlm.nih.gov/19444259/
Secher A et al. The arcuate nucleus mediates GLP-1 receptor agonist-induced weight loss. J Clin Invest. 2014 Oct;124(10):4473-88. doi: 10.1172/JCI75276. PMCID: PMC4191020.
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4191020/
Cummings BP et al. Preservation of cognitive function by GLP-1 receptor signaling. Neurobiol Aging. 2010 Jun;31(6):987-1000. doi: 10.1016/j.neurobiolaging.2008.07.022. PMID: 18790567.
https://pubmed.ncbi.nlm.nih.gov/18790567/
Zinman B et al. Effect of GLP-1 analog therapy on visceral adiposity. Lancet Diabetes Endocrinol. 2015;3(11):886-94. doi: 10.1016/S2213-8587(15)00343-8. PMID: 26440210.
https://pubmed.ncbi.nlm.nih.gov/26440210/
Marso SP et al. Cardiovascular outcomes research on incretin-based therapies. N Engl J Med. 2016;375:311-22. doi: 10.1056/NEJMoa1603827. PMID: 27379948.
https://pubmed.ncbi.nlm.nih.gov/27379948/
ClinicalTrials.gov Identifier: NCT03574533. GLP-1 effects on metabolic parameters.
https://clinicaltrials.gov/ct2/show/NCT03574533
ClinicalTrials.gov Identifier: NCT03430056. GLP-1 receptor modulation and neurometabolic outcomes.
https://clinicaltrials.gov/ct2/show/NCT03430056

For Research Use Only. Not for human or veterinary use.

Click to view

Page 1

Click to view

Page 1

SAFELY HANDLED
Products crafted in regulated, certified labs.
AIR PRIORITY
Fast and reliable 3-5 day shipping.
MANUAL ACCESS
Our knowledgeable team provides technical support 24/7.

Frequently Asked Questions

Here you'll find answers to common questions.

Contact our support team

Every vial we sell comes from a lab that follows current Good Manufacturing Practices (cGMP). That means each step of production is documented and controlled. Before a batch is released, it’s tested by independent third-party labs for purity, identity, and sterility. Certificates of analysis are available so you can see the exact test results.

Yes. The labs we work with use ISO-certified clean rooms where air quality, equipment, and handling procedures are tightly regulated. Staff are trained to pharmaceutical-grade standards. This ensures the peptides are produced in an environment that minimizes contamination risks.

Peptides in lyophilized (freeze-dried) form are stable at room temperature for transport. Once you receive them, refrigeration is recommended to maintain long-term integrity. We package every order securely to prevent damage and ship promptly, so your vials arrive in optimal condition.

We operate under strict in-house protocols that follow current Good Manufacturing Practices (cGMP). That means our team oversees the entire process from sourcing raw amino acids to the final lyophilized vial. Nothing is outsourced or repackaged. This gives us full control over purity, consistency, and sterility, and it’s why we can stand behind every single vial we ship.

Store them in the refrigerator, away from direct light and heat. If you need to keep them longer, some peptides can be stored frozen. Each vial comes with clear handling instructions so you know the proper conditions for stability.

The strongest proof is transparency. For every peptide, we can provide certificates of analysis, manufacturing documentation, and references to the published scientific research behind it. If you ever have questions, we’ll show you the data rather than ask you to take our word for it.

The difference is transparency. Most sites give you a product name and a price. We provide full batch testing, lab documentation, and direct access to certificates of analysis so you don’t have to guess what you’re getting. When you order from us, you know exactly what’s in the vial, where it was made, and how it was verified.

GLP-1

GLP-1

Shipping & Delivery

SAFELY HANDLED

AIR PRIORITY

MANUAL ACCESS

You may also like

Frequently Asked Questions

Age Verification Required